Intellia Therapeutics, Inc. (NTLA)

NASDAQ: NTLA · Real-Time Price · USD

10.73

-0.37 (-3.33%)

At close: Jul 24, 2026, 4:00 PM EDT

11.02

+0.29 (2.70%)

Pre-market: Jul 27, 2026, 5:30 AM EDT

Intellia Therapeutics Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	66.09	67.67	57.88	36.28	52.12	33.05
Revenue Growth	45.04%	16.92%	59.55%	-30.40%	57.69%	-43.01%
Gross Profit	66.09	67.67	57.88	36.28	52.12	33.05
Operating Income	-420.72	-440.99	-534.26	-515.29	-458.16	-267.85
Net Income	-394.6	-412.69	-519.02	-481.19	-474.19	-267.89
Earnings Per Share	-3.54	-3.81	-5.25	-5.42	-6.16	-3.78
EPS Growth	-	-	-	-	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	375.99	449.88	601.52	912.22	1,193	748.69
Total Debt	80.49	93.33	210.2	115.35	130.7	74.02
Net Cash (Debt)	295.5	356.56	391.32	796.88	1,062	674.67
Net Cash Growth	-23.15%	-8.88%	-50.89%	-24.96%	57.40%	20.89%
Net Cash Per Share	2.64	3.29	3.96	8.98	13.80	9.52

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-363.15	-394.74	-348.88	-394.09	-333.29	-225.03
Capital Expenditures	-0.47	-1.13	-5.78	-13.99	-13.56	-12.76
Free Cash Flow	-363.63	-395.87	-354.66	-408.07	-346.85	-237.79
Free Cash Flow Growth	-	-	-	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	-636.56%	-651.67%	-923.10%	-1420.51%	-879.04%	-810.37%
Pretax Margin	-597.04%	-609.85%	-896.77%	-1326.51%	-909.78%	-810.49%
Profit Margin	-597.04%	-609.85%	-896.77%	-1326.51%	-909.78%	-810.49%
FCF Margin	-550.18%	-584.99%	-612.78%	-1124.94%	-665.46%	-719.41%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	22.68	15.45	20.56	78.17	58.31	266.46